Key Takeaways
- Cranswick (LSE: CWK) reached a fresh record high of around 5,620p in 2026, with the shares trading near that level in late May.
- The group's FY2026 results showed Revenue up 9.5% to £2,982.5m and adjusted operating profit up 14.5% to £237.0m.
- The board has proposed a final Dividend of 85.5p, taking the total payout to 112.5p — a 36th consecutive year of dividend growth.
- Strong poultry momentum, capacity expansion at Eye and free Cash Flow growth have underpinned investor confidence.
- Risks remain around input costs, animal health, ESG scrutiny and the pace of consumer spending.
Introduction
Cranswick Plc (LON: CWK) has emerged as one of the most consistent UK food sector growth stories. The East Yorkshire-based pork, poultry and convenience-food group has steadily compounded Earnings and dividends for decades, and in 2026 it has been rewarded by a fresh all-time high in its share price.
The latest leg up has been driven by a strong full-year trading performance, an enhanced dividend and a confident Capital-spending plan that points to multiple years of incremental capacity coming on stream. Investors looking for defensive UK exposure with growth optionality have found Cranswick an attractive proposition in a market that has otherwise tilted toward technology and financials.
This article reviews what is behind the move, where the Business sits within the broader UK food sector, the financial picture and the risks that investors are watching as they decide whether the momentum is durable.
What Happened to Cranswick Shares?
Cranswick shares set a new all-time high in 2026, with publicly available pricing data showing a 52-week range stretching from around 4,805p at the lows to 5,620p at the highs. As of 27 May 2026, the shares were quoted at approximately 5,500p, leaving them within touching distance of the record.
The trigger for the breakout was the company's preliminary FY2026 results, published in May 2026, which showed all-round operational and financial progress. The shares had already been on an upward path through 2025, supported by a series of solid trading updates, including a Christmas trading statement that flagged 'record' festive trading.
Sentiment was reinforced by an upgrade in Margin/">Operating Margin guidance and confident commentary on capital projects. Analyst consensus has subsequently lifted, with a target price in the region of 5,891p, well above the prevailing share price, although individual broker views vary. Trading volumes have remained healthy, with both institutional and retail investors holding the stock.
Why the Stock Is Trading Near an All-Time High
A number of forces have lifted Cranswick to record territory. First, the FY2026 results, covering the year to March 2026, were broadly ahead of consensus and confirmed that the group is converting top-line growth into stronger profit at scale. Revenue rose 9.5% to £2,982.5m and adjusted operating profit rose 14.5% to £237.0m, taking adjusted operating margin to 7.9%.
Second, the dividend story remains a key part of the bull case. The board has proposed a final dividend of 85.5p, a 12.5% increase on the prior year, taking the total dividend to 112.5p per share. That marks a 36th consecutive year of dividend growth — a record that few UK-listed peers can match.
Third, the company is investing heavily for the future. Capital Expenditure is supporting major projects in pork, poultry and Supply-chain Assets, including a £56m poultry expansion in Eye, Suffolk. Far from being viewed as a cash drag, this spend has been welcomed by long-term shareholders as evidence that management is locking in future capacity at favourable returns.
Finally, the cash generation profile is impressive. Free cash flow rose 25.7% to £268.4m in FY2026, helping the company fund growth Investment while still returning higher dividends. With net Debt remaining modest relative to EBITDA, the Balance Sheet is not under pressure. The combination of growth, income and defensiveness has been particularly well received in the current UK market backdrop.
Company Background
Cranswick traces its roots back to the 1970s as a feed business in East Yorkshire. Today it is one of the United Kingdom's largest food producers, with operations spanning fresh pork, gourmet sausages, cooked meats, premium and continental products, breaded poultry and pet food, as well as a growing presence in convenience and ingredients.
The group's customer base is anchored by major UK grocery retailers, including all the leading multiples, as well as a growing footprint in food service and exports. Cranswick is vertically integrated in pork, with its own farming operations, processing sites and value-added facilities. In poultry, the business has grown rapidly in recent years through both organic investment and the Acquisition of capacity at sites including Eye in Suffolk.
Cranswick is headquartered in Hessle, near Hull, and is a long-standing member of the FTSE 250. Its Market Capitalisation, at recent share-price levels, places it at the larger end of the mid-cap food cohort. The group employs thousands of staff across the UK and has invested significantly in higher-welfare animal husbandry, traceability and sustainability programmes — a key consideration for both retail customers and ESG-focused investors.
Sector and Market Context
The UK food producer sector has had a mixed few years. Volatile input costs — driven by feed, energy and labour — have squeezed margins across the industry, while customers have pushed back on price increases. Against that backdrop, Cranswick's ability to grow operating margin to 7.9% is notable.
Cranswick has benefitted from several structural trends. Consumer Demand for higher-welfare and premium meat has supported richer mix. Convenience and food-to-go continue to grow as eating habits shift. Poultry remains a fast-growing protein globally, with demand outpacing many other meat categories. The export market — particularly Asia for pork — has provided incremental opportunity.
The wider UK Equity backdrop also matters. UK mid-cap consumer staples have been re-rated modestly in 2026 as investors search for resilient earnings amid still-elevated geopolitical and macro uncertainty. Cranswick's combination of defensive end markets, strong cash generation and a long dividend record makes it a natural beneficiary.
That said, the sector is competitive. Major peers and own-label producers compete fiercely for retailer contracts, and any disruption — whether from disease outbreaks, labour shortages or Commodity moves — can quickly affect profitability.
Financial Performance and Key Data
Cranswick's FY2026 results, covering the year to March 2026, illustrated the strength of the Franchise. Headline numbers — all of which should be verified before publication — show revenue of £2,982.5m (up 9.5% year on year), adjusted operating profit of £237.0m (up 14.5%), adjusted operating margin of 7.9%, adjusted Earnings Per Share of 301.7p (up 10.4%), a proposed final dividend of 85.5p (up 12.5%) and a total dividend of 112.5p — a 36th consecutive year of dividend growth.
Cash generation was a standout: free cash flow rose 25.7% to £268.4m. By category, poultry revenue rose 13.9%, with growth across fresh, prepared and cooked products. Pork sales rose 3%, with volumes up 5%. The Capital Investment programme includes a £56m poultry expansion at Eye and continued spending across the pork, poultry and supply-chain estate.
The Dividend Yield, based on a share price near 5,500p and a total dividend of 112.5p, sits at around 2%, with cover comfortably above 2.5 times on adjusted earnings.
Valuation looks elevated relative to the long-run average — the forward earnings multiple has expanded materially as the business has been re-rated for higher margins and structural growth. Net debt to EBITDA remains modest, providing further capacity to invest. Analyst consensus appears constructive: the consensus price target is in the region of 5,891p, with several houses on 'buy' or equivalent. Investors should treat consensus figures as a guide, not a forecast.
Investor Sentiment and Market Reaction
Sentiment toward Cranswick has improved materially over the past year. Institutional investors with a focus on quality, growth and income have warmed to the combination of a strong dividend record, double-digit profit growth and meaningful capacity expansion.
Retail investor engagement has also been robust, with the stock featuring on many UK income lists and 'dividend hero' screens. The 36th consecutive year of dividend growth is a powerful narrative point for UK-focused investors looking for reliable cash returns.
The market reaction to the FY2026 results was positive, with the shares pushing higher on results day and then continuing to trade near record territory through May 2026. Analysts have generally raised their estimates and targets, although a minority remain more cautious on valuation grounds.
Risks and Challenges
Despite the strong narrative, there are clear risks. First, animal disease — including avian influenza and African swine fever — can disrupt supply, drive cost Inflation and force operational changes. The group has a strong track record of managing biosecurity, but the risk cannot be eliminated.
Second, input costs remain volatile. Feed prices, energy costs and labour costs can all shift quickly, and while Cranswick has demonstrated pricing power, retailer negotiations can constrain how much can be passed on.
Third, customer concentration is meaningful. UK grocery customers exert significant negotiating power, and any change to volumes, contracts or terms could affect performance.
Fourth, ESG scrutiny of the meat industry continues to grow. Sustainability and welfare standards are rising, and investor expectations around emissions are becoming more demanding.
Finally, valuation risk remains a Factor. The shares have re-rated significantly and now leave less margin for error. A profits warning or material macro shock could trigger a sharper share-price response than past cycles suggest. Investors should review the company's filings and trading updates carefully.
What Could Move the Stock Next?
Several near-term factors could shape Cranswick's share price. The next trading update is likely to come ahead of the half-year results, with investors watching summer trading and the early ramp-up of capacity expansions.
Christmas trading is a key seasonal moment for the business; another 'record' festive period could reinforce momentum into 2027 forecasts. The progress of the £56m Eye poultry expansion and other capital projects will be closely monitored for any sign of delays or cost overruns.
Macro factors matter too. The path of UK consumer spending, inflation and food retailer margins could influence performance. Any change to UK pork or poultry export rules — particularly to Asia — could open or close opportunities.
Capital allocation will also be in focus. Cranswick has historically combined organic investment, M&Amp;A and progressive dividends. Any bolt-on acquisition, a Special Dividend or a buyback would shift the narrative. Analyst upgrades or downgrades, particularly relative to the current 5,891p consensus target, will also affect sentiment.
Bottom Line
Cranswick's run to all-time highs is anchored in real operational progress: record revenue, double-digit profit growth, a 36th consecutive year of dividend increases and a confident capital-spending plan. For UK investors searching for resilient, dividend-paying mid-cap exposure, the appeal is clear. That said, the valuation has expanded and the meat industry is not without risk. Animal health, input costs, customer power and ESG considerations all need careful attention. Investors are watching summer trading, Christmas seasonality and Capital Project execution to gauge whether the strong run can continue.






Please wait processing your request...